Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin C PK in Cardiac Surgery
NCT03123107Phase 1Completed
- Sponsor
- Geisinger
- Start
- Jul 2017
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of ascorbic acid in Atrial fibrillation (AFib), sponsored by Geisinger. Primary endpoints: Ascorbate maximum serum concentration at 1 year, Half-life of serum ascorbate at 1 year and 3 more. Started Jul 2017; status: completed.
02
Drugs
ascorbic acid
03
Conditions
Atrial fibrillation (AFib)
Beyond the preview
Go deeper on NCT03123107.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03123107.